Abeona Therapeutics Inc (ABEO) support and resistance · rev $3.5M
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
This page maps Abeona Therapeutics Inc (ABEO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
ABEO currently screens at market cap $301.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ABEO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ABEO quote page for the session range and the stock page for the full model.
Not investment advice.